Research Alert

Newswise — The generation of off-the-shelf CAR-T cells from TiPSCs has been hindered by the difficulty to recapitulate adaptive T cell development and lower therapeutic efficacy compared to peripheral blood CAR-T cells. Ueda et al. address these issues in a triple-engineering strategy, combining optimized CAR expression with cytolytic and persistence enhancements.

Journal Link: Publisher Website Journal Link: Download PDF

Register for reporter access to contact details

DOI link; Publisher Website; Download PDF